MSK1 regulates homeostatic and experience-dependent synaptic plasticity

J Neurosci. 2012 Sep 19;32(38):13039-51. doi: 10.1523/JNEUROSCI.0930-12.2012.

Abstract

The ability of neurons to modulate synaptic strength underpins synaptic plasticity, learning and memory, and adaptation to sensory experience. Despite the importance of synaptic adaptation in directing, reinforcing, and revising the behavioral response to environmental influences, the cellular and molecular mechanisms underlying synaptic adaptation are far from clear. Brain-derived neurotrophic factor (BDNF) is a prime initiator of structural and functional synaptic adaptation. However, the signaling cascade activated by BDNF to initiate these adaptive changes has not been elucidated. We have previously shown that BDNF activates mitogen- and stress-activated kinase 1 (MSK1), which regulates gene transcription via the phosphorylation of both CREB and histone H3. Using mice with a kinase-dead knock-in mutation of MSK1, we now show that MSK1 is necessary for the upregulation of synaptic strength in response to environmental enrichment in vivo. Furthermore, neurons from MSK1 kinase-dead mice failed to show scaling of synaptic transmission in response to activity deprivation in vitro, a deficit that could be rescued by reintroduction of wild-type MSK1. We also show that MSK1 forms part of a BDNF- and MAPK-dependent signaling cascade required for homeostatic synaptic scaling, which likely resides in the ability of MSK1 to regulate cell surface GluA1 expression via the induction of Arc/Arg3.1. These results demonstrate that MSK1 is an integral part of a signaling pathway that underlies the adaptive response to synaptic and environmental experience. MSK1 may thus act as a key homeostat in the activity- and experience-dependent regulation of synaptic strength.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Brain-Derived Neurotrophic Factor / pharmacology
  • Cells, Cultured
  • Cytoskeletal Proteins / metabolism
  • Dendritic Spines / physiology
  • Environment
  • Enzyme Inhibitors / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / genetics
  • Female
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Green Fluorescent Proteins / genetics
  • Hippocampus / cytology
  • Homeostasis / drug effects
  • Homeostasis / genetics*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nerve Tissue Proteins / metabolism
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / genetics*
  • Neurons / metabolism*
  • Neurons / ultrastructure
  • Patch-Clamp Techniques
  • Point Mutation / genetics
  • Receptors, AMPA / metabolism
  • Ribosomal Protein S6 Kinases, 90-kDa / genetics
  • Ribosomal Protein S6 Kinases, 90-kDa / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Sodium Channel Blockers / pharmacology
  • Synapses / genetics
  • Synapses / physiology*
  • Tetrodotoxin / pharmacology
  • Time Factors

Substances

  • Brain-Derived Neurotrophic Factor
  • Cytoskeletal Proteins
  • Enzyme Inhibitors
  • Nerve Tissue Proteins
  • Receptors, AMPA
  • Sodium Channel Blockers
  • activity regulated cytoskeletal-associated protein
  • Green Fluorescent Proteins
  • Tetrodotoxin
  • Ribosomal Protein S6 Kinases, 90-kDa
  • mitogen and stress-activated protein kinase 1
  • glutamate receptor ionotropic, AMPA 2
  • glutamate receptor ionotropic, AMPA 1